SyloSpace

What is pneumonic plague and how does it spread?

Pneumonic plague is the severe lung form of plague that spreads person-to-person less easily than commonly assumed, but is highly fatal if untreated.

Updated 1 hour ago6 min readVersion 2
CommentsFollow

Covers: This page explains what pneumonic plague is, its causes, symptoms, and the ways it spreads between people and from animals. It does not cover bubonic or septicemic plague in detail, nor detailed treatment protocols.

3 free full reads left this month. Join or upgrade

Chest x-ray showing bilateral infiltrates and cardiomegaly
Photo: CDC

The short answer

Interpretation AI-prepared starting map

Pneumonic plague is the form of plague in which the bacterium Yersinia pestis infects the lungs. It can arise two ways: as a complication of bubonic or septicemic plague (secondary pneumonia), or directly by inhaling infectious droplets from a person or animal with pneumonic plague (primary pneumonic plague). It is the most severe form of plague, with rapid onset and high mortality if untreated — one review puts untreated mortality at 90–95%, falling to 5–18% with appropriate treatment. Person-to-person spread is real but less efficient than commonly assumed: a quantitative analysis of past outbreaks estimated an average of about 1.3 secondary cases per primary case (R0 = 1.3) before control measures, and a review of all US primary pneumonic plague cases from 1900–2009 found most cases transmit to no one, even without treatment, though superspreading events can sustain outbreaks.1234

What this rests on6 independent sources
  • Evidence 21
  • Interpretation 1

In brief

  1. Pneumonic plague is the lung form of plague caused by Yersinia pestis, arising either as a complication of bubonic/septicemic plague or by inhaling infectious droplets (primary pneumonic plague).42

    Evidence-backed
  2. Person-to-person spread happens mainly through close contact with a person in the end stage of illness coughing bloody sputum; simple measures like masks and avoiding close contact interrupted transmission in past outbreaks before antibiotics were available.5

    Evidence-backed
  3. Transmission is less efficient than commonly believed: estimated R0 was about 1.3 before control measures, and most US primary pneumonic plague cases from 1900–2009 transmitted to no one, though superspreading events can still sustain outbreaks.12

    Evidence-backed
  4. Untreated pneumonic plague is highly fatal (90–95% in one review; approaching 100% in another), but appropriate treatment reduces mortality to roughly 5–18%.34

    Evidence-backed
  5. Pneumonic plague is a recognized bioterrorism concern because aerosolized Yersinia pestis would cause many simultaneous primary cases, and antibiotic-resistant strains cannot be excluded.54

    Evidence-backed

At a glance

The picture in numbers

Live · updated just now

One review of pneumonic plague outcomes
  • Untreated (low)90%
  • Untreated (high)95%
  • Treated (low)5%
  • Treated (high)18%
Untreated vs treated mortality from pneumonic plague34
Modelling estimate from past outbreaks

3.1 variance

3.1 variance: Variance reported for the R0 estimate1
Modelling estimate from past outbreaks

4.3 days

4.3 days: Mean latent period in the transmission model1

The evidence behind it

6 sources
  • Other studies and data6

When it was published

Newest from 2020

20022026
Sources on this page by kind and year
SourceKindYear
Risk of Person‐to‐Person Transmission of Pneumonic PlagueOther studies and data2005
Epidemiologic Determinants for Modeling Pneumonic Plague OutbreaksOther studies and data2004
Transmission dynamics of primary pneumonic plague in the USAOther studies and data2011
Yersinia pestis: the Natural History of PlagueOther studies and data2020
Pneumonia Caused by Yersinia pestis: Plague PneumoniaOther studies and data2006
[Yersinia pestis as a dangerous biological weapon].Other studies and data2002

The community around it

Contributions
0
People
0
Following
0

Nobody has added anything yet. Experience, evidence or a different view would show up here.

What it means for you

Which fits you?

Pick the situation closest to yours. Each answer says what it rests on.

If you are a clinician assessing a patient with severe pneumonia and relevant travel or animal exposure

maintain a high index of suspicion for plague pneumonia, assess travel and vector or animal exposure, and treat promptly, because empiric therapy may offer no second chance if it fails.3

Evidence-backed

If you are a first responder or medical worker preparing for a possible pneumonic plague event

form a realistic view of person-to-person risk: transmission usually requires close contact with an end-stage patient coughing bloody sputum, and simple measures such as masks and avoiding close contact were sufficient to interrupt past outbreaks.5

Evidence-backed

If you are planning outbreak control for a suspected pneumonic plague cluster

act without delay, because modelled outbreaks show that delays in implementing control measures and a higher number of initial cases increase total incidence.1

Evidence-backed

If you are trying to judge how worried to be about a single case spreading widely

note that most primary pneumonic plague cases transmit to no one even without treatment, but superspreading events can still sustain outbreaks, so individual risk is low while cluster potential remains.2

Evidence-backed

If you live in or travel to an area where plague is endemic in animals

be aware that the main natural transmission route is infected flea bites, which cause bubonic or septicemic plague that can secondarily involve the lungs.64

Evidence-backed

The full story · 4 chapters

01

What pneumonic plague is

AI summary:Pneumonic plague is the lung form of Yersinia pestis infection, arising either as a complication of bubonic or septicemic plague or by inhaling infectious droplets.

Evidence-backed

Evidence-backed: Plague is caused by the Gram-negative bacterium Yersinia pestis, a zoonotic disease established in stable foci in the Americas, Africa, and Eurasia. Its persistence in the environment depends on a balance between contaminated soils, burrowing and non-burrowing mammals with varying susceptibility, and their fleas. Transmission between animal hosts relies mainly on infected flea bites, which produce the classic painful, enlarged lymph nodes called buboes, followed by spread of the pathogen through the bloodstream.6

Evidence-backed

Evidence-backed: Pneumonic plague is the form in which the infection involves the lungs. It can occur as a secondary pneumonia complicating bubonic or septicemic plague, or as primary pneumonic plague when a person inhales infectious droplets. Primary pneumonic plague is described as the most severe form of the disease and is transmissible from person to person, with the potential to propagate epidemics.42

Evidence-backed

Evidence-backed: Plague pneumonia is difficult to diagnose in its early stages. It may present as pneumonia, adult respiratory distress syndrome, a surgical abdomen, undifferentiated sepsis with or without disseminated intravascular coagulation, Reye's syndrome, or lymphadenopathy. Clinicians are advised to maintain a high index of suspicion and to assess travel history and vector or animal exposure when choosing presumptive therapy for a presumed bacterial pneumonia.3

02

How it spreads

AI summary:Spread occurs mainly through close contact with a coughing end-stage patient, and past outbreaks suggest transmission is less efficient than often assumed.

Evidence-backed

Evidence-backed: The main natural route of plague transmission between animal hosts is the bite of an infected flea, which leads to bubonic or septicemic plague and can be complicated by secondary pneumonia. A person who develops pneumonic symptoms can then become a source of droplet-borne, inhalatory infection for others, who develop primary pneumonic plague. Artificially created aerosols containing plague bacilli could also cause many near-simultaneous cases of primary pulmonic plague in an exposed population.4

Evidence-backed

Evidence-backed: Person-to-person transmission of pneumonic plague is real but appears less efficient than often assumed. Historical accounts and contemporary experience indicate that people with plague usually transmit only when the disease is in its end stage, when they cough copious amounts of bloody sputum, and only through close contact. Before antibiotics were available for post-exposure prophylaxis, simple measures such as wearing masks and avoiding close contact were sufficient to interrupt transmission during pneumonic plague outbreaks.5

Evidence-backed

Evidence-backed: Quantitative modelling based on past outbreaks estimated the average number of secondary cases per primary case (R0) at 1.3 (variance 3.1) before outbreak control measures, with latent and infectious periods approximated by lognormal distributions with means (SD) of 4.3 (1.8) and 2.5 (1.2) days. The model showed that delays in implementing control measures and a higher number of initial cases increase the incidence in simulated outbreaks.1

Evidence-backed

Evidence-backed: An analysis of all primary pneumonic plague cases reported in the USA from 1900 to 2009 found that the majority of cases fail to transmit to anyone, even without antimicrobial treatment or prophylaxis. The authors argue that estimates based on large outbreaks artificially inflate the basic reproductive number and skew the distribution of individual infectiousness. They conclude that sustained outbreaks remain possible because of superspreading events, which challenges current concepts of primary pneumonic plague transmission.2

03

Severity and outcomes

AI summary:Untreated pneumonic plague is highly fatal, but appropriate treatment sharply reduces mortality, and drug resistance is a growing concern.

Evidence-backed

Evidence-backed: Plague is a severe infection with a short incubation period, rapid onset, and quick progression, with mortality exceeding 50% if not treated properly. Pneumonic plague in particular progresses especially rapidly, with a mortality rate approaching 100% if not treated properly. Untreated, plague pneumonia is fatal in 90% to 95% of cases; appropriate treatment reduces mortality to 5% to 18%.43

Evidence-backed

Evidence-backed: Treatment options are under pressure: the first reported case of multidrug-resistant Y. pestis from an epidemic area raises concern about the future of treatment and prophylaxis regimens, although quinolones and third-generation cephalosporins may hold some promise. In plague pneumonia, empiric therapy often offers no second chance if it fails, which makes early suspicion and accurate exposure assessment important.3

04

Why pneumonic plague attracts attention

AI summary:Pneumonic plague draws attention as a possible bioterrorism weapon and as a risk in areas where plague is not endemic.

Evidence-backed

Evidence-backed: Plague has received much attention because it may be used as a weapon by terrorists: intentionally released aerosols of Yersinia pestis would cause pneumonic plague. Preparing for such an event requires a realistic idea of the risk of person-to-person spread, particularly for medical personnel and first responders.5

Evidence-backed

Evidence-backed: Yersinia pestis can be easily obtained and cultured and is highly pathogenic for humans, so it poses a serious threat of use for bioterrorism. The use of strains resistant to commonly applied antibiotics cannot be excluded. Pneumonic plague also poses a potentially increasing risk to humans in regions where plague is not endemic, either through an aerosolized release or through importation of the disease.41

Ask this Sylo

Still wondering about something?

Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.

Behind this page

Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.

Discussion

Nobody has added anything yet. If you have experience, evidence or a different view, you could be the first.

Sources

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

  1. 1
    Epidemiologic Determinants for Modeling Pneumonic Plague Outbreaks
    Emerging infectious diseases (Gani & Leach)Published Apr 1, 2004Checked Oct 7, 2026
    “Pneumonic plague poses a potentially increasing risk to humans in plague nonendemic regions either as a consequence of an aerosolized release or through importation of the disease. Pneumonic plague is person-to-person transmissible. We provide a quantitative assessment of transmissibility based on past outbreaks that shows that the average number of secondary cases per primary case (R0) was 1.3 (variance = 3.1), assuming a geometric probability distribution, prior to outbreak control measures. We also show that the latent and infectious periods can be approximated by using lognormal distributions with means (SD) of 4.3 (1.8) and 2.5 (1.2) days. Based on this parameter estimation, we construct a Markov-chain epidemic model to demonstrate the potential impact of delays in implementing outbreak control measures and increasing numbers of index cases on the incidence of cases in simulated outbreaks.”
  2. 2
    Transmission dynamics of primary pneumonic plague in the USA
    Epidemiology and Infection (Hinckley et al.)Published Jul 7, 2011Checked Oct 7, 2026
    “Plague is thought to have killed millions during three catastrophic pandemics. Primary pneumonic plague, the most severe form of the disease, is transmissible from person-to-person and has the potential for propagating epidemics. Efforts to quantify its transmission potential have relied on published data from large outbreaks, an approach that artificially inflates the basic reproductive number (R(0)) and skews the distribution of individual infectiousness. Using data for all primary pneumonic plague cases reported in the USA from 1900 to 2009, we determined that the majority of cases will fail to transmit, even in the absence of antimicrobial treatment or prophylaxis. Nevertheless, potential for sustained outbreaks still exists due to superspreading events. These findings challenge current concepts regarding primary pneumonic plague transmission.”
  3. 3
    Pneumonia Caused by Yersinia pestis: Plague Pneumonia
    Kluwer Academic Publishers eBooks (Cleri et al.)Published Jan 5, 2006Checked Oct 7, 2026
    “With the first reported case of multidrug-resistant Y. pestis from an epidemic area, the future of treatment and prophylaxis regimens may be problematic, although quinolones and third-generation cephalosporins may hold some promise. Plague, and especially plague pneumonia, in their early presentations are difficult to diagnose. One must maintain a high index of suspicion and be sure to accurately assess a patient’stravel and vector or animal exposure when choosing presumptive therapy for a presumed bacterial pneumonia. A disease that may present itself as a pneumonia, adult respiratory distress syndrome, a surgical abdomen, undifferentiated sepsis with or without DIC, Reye’s syndrome, or any form of lymphadenopathy with or 0. without the above presentations is a diagnostic and treatment challenge. This is especially true in patients with plague pneumonia, where often there will be no second chance at therapy if empiric therapy fails. Untreated, the disease is fatal in 90% to 95% of cases. Appropriate treatment reduces mortality to 5% to 18% (Cleri et al., 1997).”
  4. 4
    [Yersinia pestis as a dangerous biological weapon].
    PubMed (Grygorczuk & Hermanowska-Szpakowicz)Published Jan 1, 2002Checked Oct 7, 2026
    “Infection by flea bite results in a bubonic or septicemic plague, possibly complicated by secondary pneumonia. The person with pneumonic symptoms may be a source of a droplet-borne inhalatory infection for other people who consequently develop primary pneumonic plague. Despite a clinical form, plague is a severe infection characterized by a short incubation period, rapid onset and quick progress with mortality exceeding 50% if not treated properly. The pneumonic plague is associated with a particularly rapid progress and the mortality rate of almost 100% if not treated properly. As Yersinia pestis can be easily obtained and cultured and is highly pathogenic for humans, it poses a serious threat of being used for bioterrorism purposes. Artificially created aerosol containing plague bacilli can cause numerous and almost simultaneous cases of primary pulmonic plague in an exposed population. Persons exposed would most likely develop severe pneumonia with rapidly progressing respiratory and circulatory failure. The use of the Yersinia pestis strains resistant to antibiotics typically applied cannot be excluded.”
  5. 5
    Risk of Person‐to‐Person Transmission of Pneumonic Plague
    Clinical Infectious Diseases (Kool)Published Mar 29, 2005Checked Oct 7, 2026
    “Plague has received much attention because it may be used as a weapon by terrorists. Intentionally released aerosols of Yersinia pestis would cause pneumonic plague. In order to prepare for such an event, it is important, particularly for medical personnel and first responders, to form a realistic idea of the risk of person-to-person spread of infection. Historical accounts and contemporary experience show that pneumonic plague is not as contagious as it is commonly believed to be. Persons with plague usually only transmit the infection when the disease is in the endstage, when infected persons cough copious amounts of bloody sputum, and only by means of close contact. Before antibiotics were available for postexposure prophylaxis for contacts, simple protective measures, such as wearing masks and avoiding close contact, were sufficient to interrupt transmission during pneumonic plague outbreaks. In this article, I review the historical literature and anecdotal evidence regarding the risk of transmission, and I discuss possible protective measures.”
  6. 6
    Yersinia pestis: the Natural History of Plague
    Clinical Microbiology Reviews (Barbieri et al.)Published Dec 8, 2020Checked Oct 7, 2026
    “The Gram-negative bacterium Yersinia pestis is responsible for deadly plague, a zoonotic disease established in stable foci in the Americas, Africa, and Eurasia. Its persistence in the environment relies on the subtle balance between Y. pestis -contaminated soils, burrowing and nonburrowing mammals exhibiting variable degrees of plague susceptibility, and their associated fleas. Transmission from one host to another relies mainly on infected flea bites, inducing typical painful, enlarged lymph nodes referred to as buboes, followed by septicemic dissemination of the pathogen.”

How it changed

Published 1 time since Oct 7, 2026.

  1. Version 2Oct 7, 2026Live now

    AI-prepared Starting Map from live research.

    • First published version.
Every version, side by side

Help improve it

The brief is open about what's uncertain. These are the specific gaps that new material would fill.

Open questions

  • What conditions turn an individual case into a superspreading event, and how often do such events occur in modern settings?

    No answers yet

  • How do the historical transmission estimates (R0 ~1.3, most cases transmitting to no one) compare with transmission under modern hospital care and rapid antibiotic use?

    No answers yet

  • How much of the total transmission risk comes from natural droplet spread versus a deliberately aerosolized release?

    No answers yet

Around this topic

Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.

Add what you know

Sign in to add what you know. Reading stays open to everyone.

Ask this Sylo

Answers only from “What is pneumonic plague and how does it spread?”

Ask anything about this page. The AI reads only its reviewed brief, sources and contributions, cites what it used, and says when the page doesn't cover something.